Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum

Intensive Care Medicine

Volumn 42, Issue 9, 2016, Pages 1387-1397

  Andreis, Davide Tommaso ^a,b   Singer, Mervyn ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Catecholamines; Critical illness; Epinephrine; Norepinephrine; Pathophysiology; Physiology; Sepsis

Indexed keywords

CATECHOLAMINE;

ADRENAL MEDULLA; AUTONOMIC NERVOUS SYSTEM; CARDIAC MUSCLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHRONOTROPISM; ENERGY CONSUMPTION; GASTROINTESTINAL TRACT; HEMOSTASIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INOTROPISM; METABOLIC REGULATION; NONHUMAN; PERIPHERAL CIRCULATION; REVIEW; SHOCK; CRITICAL ILLNESS; DRUG EFFECTS; HOMEOSTASIS; NERVOUS SYSTEM; PHYSIOLOGY; SHOCK, SEPTIC;

CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CRITICAL ILLNESS; HOMEOSTASIS; HUMANS; NERVOUS SYSTEM; SHOCK, SEPTIC;

EID: 84957942004     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-016-4249-z     Document Type: Review

References (109)

1. Beutler B, Hoebe K, Du X et al (2003) How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74:479–485
2. Tang D, Kang R, Coyne CB et al (2012) PAMPs and DAMPs: signals that spur autophagy and immunity. Immunol Rev 249:158–175
3. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521
4. Abraham E, Singer M (2007) Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408–2416
5. Spronk PE, Zandstra DF, Ince C (2004) Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 8:462–468
6. Brealey D, Brand M, Hargreaves I et al (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223
7. Hochachka PW, Buck LT, Doll CJ et al (1996) Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 93:9493–9498
8. Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599–1608
9. Landesberg G, Gilon D, Meroz Y et al (2012) Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33:895–903
10. Spies C, Haude V, Fitzner R et al (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113:1055–1063
11. Maeder M, Fehr T, Rickli H, Ammann P (2006) Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:1349–1366
12. Parker MM, Shelhamer JH, Bacharach SL et al (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483–490
13. Kimmoun A, Ducroq N, Levy B (2013) Mechanisms of vascular hyporesponsiveness in septic shock. Curr Vasc Pharmacol 11:139–149
14. Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125
15. Bucher M, Ittner KP, Hobbhahn J et al (2001) Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 38:177–182
16. Woolf PD, Hamill RW, Lee LA et al (1988) Free and total catecholamines in critical illness. Am J Physiol 254:E287–E291
17. Lin IY, Ma HP, Lin AC et al (2005) Low plasma vasopressin/norepinephrine ratio predicts septic shock. Am J Emerg Med 23:718–724
18. Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374–381
19. Krasel C, Vilardaga JP, Bünemann M et al (2004) Kinetics of G-protein-coupled receptor signalling and desensitization. Biochem Soc Trans 32:1029–1031
20. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42:33–84
21. Perlman RL, Chalfie M (1977) Catecholamine release from the adrenal medulla. Clin Endocrinol Metab 6:551–576
22. Schaper J, Meiser E, Stämmler G (1985) Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res 56:377–391
23. Ellison GM, Torella D, Karakikes I et al (2007) Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem 282:11397–11409
24. Karch SB (1987) Resuscitation-induced myocardial necrosis. Catecholamines and defibrillation. Am J Forensic Med Pathol 8:3–8
25. De Jonge WJ (2013) The gut’s little brain in control of intestinal immunity. ISRN Gastroenterol 2013:630159
26. Yang S, Koo DJ, Zhou M, Chaudry IH et al (2000) Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 279:G1274–G1281
27. Zhou M, Das P, Simms HH, Wang P (2005) Gut-derived norepinephrine plays an important role in up-regulating IL-1beta and IL-10. Biochim Biophys Acta 1740:446–452
28. Yang S, Zhou M, Chaudry IH, Wang P (2001) Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol 281:G1014–G1021
29. Adeva-Andany M, López-Ojén M, Funcasta-Calderón R et al (2014) Comprehensive review on lactate metabolism in human health. Mitochondrion 17:76–100
30. Von Känel R, Dimsdale JE (2000) Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 65:357–369
31. Mignini F, Streccioni V, Amenta F (2003) Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol 23:1–25
32. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ et al (2007) Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449:721–725
33. Sternberg EM (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6:318–328
34. Wenisch C, Parschalk B, Weiss A et al (1996) High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production. Clin Diagn Lab Immunol 3:423–428
35. Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487–525
36. Huang HW, Tang JL, Han XH et al (2013) Lymphocyte-derived catecholamines induce a shift of Th1/Th2 balance toward Th2 polarization. Neuroimmunomodulation 20:1–8
37. Lyte M, Freestone PP, Neal CP et al (2003) Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 361:130–135
38. Freestone PP, Haigh RD, Lyte M (2007) Specificity of catecholamine-induced growth in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. FEMS Microbiol Lett 269:221–228
39. Freestone PP, Hirst RA, Sandrini SM et al (2012) Pseudomonas aeruginosa–catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia? Chest 142:1200–1210
40. Messenger AJ, Barclay R (1983) Bacteria, iron and pathogenicity. Biochem Educ 11:54–62
41. Sandrini S, Alghofaili F, Freestone PP et al (2014) Host stress hormone norepinephrine stimulates pneumococcal growth, biofilm formation and virulence gene expression. BMC Microbiol 14:180
42. Freestone PP, Haigh RD, Lyte M (2008) Catecholamine inotrope resuscitation of antibiotic-damaged staphylococci and its blockade by specific receptor antagonists. J Infect Dis 197:1044–1052
43. Karavolos MH, Winzer K, Williams P et al (2013) Pathogen espionage: multiple bacterial adrenergic sensors eavesdrop on host communication systems. Mol Microbiol 87:455–465
44. Cogan TA, Thomas AO, Rees LE et al (2007) Norepinephrine increases the pathogenic potential of Campylobacter jejuni. Gut 56:1060–1065
45. Prass K, Meisel C, Hoflich C et al (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725–736
46. Chamorro A, Urra X, Planas AM (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38:1097–1103
47. Chamorro A, Amaro S, Vargas M et al (2007) Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 252:29–35
48. Wu HP, Chung K, Lin CY, Jiang BY et al (2013) Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis. Inflamm Res 62:751–763
49. Rizza RA, Cryer PE, Haymond MW et al (1980) Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism 29:1155–1163
50. Savary S, Trompier D, Andréoletti P, Le Borgne F et al (2012) Fatty acids - induced lipotoxicity and inflammation. Curr Drug Metab 13:1358–1370
51. Kjekshus JK, Mjos OD (1972) Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest 51:1767–1776
52. Treggiari MM, Romand JA, Burgener D et al (2002) Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med 30:1334–1339
53. 2 content gradients and lactate-to-pyruvate ratios. Am J Physiol Gastrointest Liver Physiol 288:G586–G592
54. Coopersmith CM, Stromberg PE, Davis CG et al (2003) Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31:1630–1637
55. Vlisidou I, Lyte M, van Diemen PM et al (2004) The neuroendocrine stress hormone norepinephrine augments Escherichia coli O157:H7-induced enteritis and adherence in a bovine ligated ileal loop model of infection. Infect Immun 72:5446–5451
56. Chen C, Lyte M, Stevens MP, Vulchanova L et al (2006) Mucosally-directed adrenergic nerves and sympathomimetic drugs enhance non-intimate adherence of Escherichia coli O157:H7 to porcine cecum and colon. Eur J Pharmacol 539:116–124
57. Green BT, Lyte M, Kulkarni-Narla A et al (2003) Neuromodulation of enteropathogen internalization in Peyer’s patches from porcine jejunum. J Neuroimmunol 141:74–82
58. Whitelaw BC, Prague JK, Mustafa OG et al (2014) Phaeochromocytoma crisis. Clin Endocrinol 80:13–22
59. Wittstein IS, Thiemann DR, Lima JA et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548
60. Guglin M, Novotorova I (2011) Neurogenic stunned myocardium and takotsubo cardiomyopathy are the same syndrome: a pooled analysis. Congest Heart Fail 17:127–132
61. Ostrowski SR, Pedersen SH, Jensen JS et al (2013) Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 17:R32
62. Venugopalan P, Argawal AK (2003) Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy. Eur J Heart Fail 5:655–658
63. Tage-Jensen U, Henriksen JH, Christensen E et al (1988) Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol 6:350–358
64. Feibel JH, Hardy PM, Campbell RG et al (1977) Prognostic value of the stress response following stroke. JAMA 238:1374–1376
65. Johansson PI, Stensballe J, Rasmussen LS et al (2012) High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 72:428–436
66. Ostrowski SR, Gaïni S, Pedersen C et al (2015) Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study. J Crit Care 2015(30):90–96
67. Reuben DB, Talvi SLA, Rowe JW et al (2000) High urinary catecholamine excretion predicts mortality and functional decline in high-functioning, community-dwelling older persons: MacArthus Studies of Successful Aging. J Gerontol A Biol Sci Med Sci 55:M618–M624
68. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
69. Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226–2234
70. Abraham WT, Adams KF, Fonarow GC et al (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46:57–64
71. Shahin J, DeVarennes B, Tse CW et al (2011) The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 15:R162
72. Boldt J, Menges T, Kuhn D et al (1995) Alterations in circulating vasoactive substances in the critically ill: a comparison between survivors and non-survivors. Intensive Care Med 21:218–225
73. Brown SM, Lanspa MJ, Jones JP et al (2013) Survival after shock requiring high-dose vasopressor therapy. Chest 143:664–671
74. Leibovici L, Gafter-Gvili A, Paul M et al (2007) Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM 100:629–634
75. Dünser MW, Ruokonen E, Pettilä V et al (2009) Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care 13:R181
76. Hagihara A, Hasegawa M, Abe T et al (2012) Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA 307:1161–1168
77. Dumas F, Bougouin W, Geri G et al (2014) Is epinephrine during cardiac arrest associated with worse outcome in resuscitated patients? J Am Coll Cardiol 64:2360–2367
78. Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583–1593
79. 2 Collaborative Group. N Engl J Med 333:1025–1032
80. López A, Lorente JA, Steingrub J et al (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21–30
81. Vincent JL, Privalle CT, Singer M et al (2015) Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). Crit Care Med 43:57–64
82. De Cruz SJ, Kenyon NJ, Sandrock CE (2009) Bench-to-bedside review: the role of nitric oxide in sepsis. Expert Rev Respir Med 3:511–521
83. Aronoff DM (2012) Cyclooxygenase inhibition in sepsis: is there life after death? Mediat Inflamm 2012:696897
84. Chawla LS, Busse L, Brasha-Mitchell E et al (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18:534–539
85. Lange M, Morelli A, Westphal M (2008) Inhibition of potassium channels in critical illness. Curr Opin Anaesthesiol 21:105–110
86. Schortgen F, Clabault K, Katsahian S et al (2012) Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095
87. Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887
88. Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638–644
89. Hamdulay SS, Al-Khafaji A, Montgomery H (2006) Glucose–insulin and potassium infusions in septic shock. Chest 129:800–804
90. Orme RM, Perkins GD, McAuley DF et al (2014) An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial. Trials 15:199
91. Saito T, Takanashi M, Gallagher E et al (1995) Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 21:204–210
92. Sakaue M, Hoffman BB (1991) Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 88:385–389
93. Annane D, Bellissant E (2000) Prognostic value of cortisol response in septic shock. JAMA 284:308–309
94. Sprung CL, Annane D, Keh D (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124
95. Morelli A, Ertmer C, Westphal M et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683–1691
96. Ackland GL, Yao ST, Rudiger A et al (2010) Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 38:388–394
97. Christensen S, Johansen MB, Tønnesen E et al (2011) Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study. Crit Care 15:R87
98. Macchia A, Romero M, Comignani PD et al (2012) Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 40:2768–2772
99. Aboab J, Sebille V, Jourdain M et al (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37:1344–1351
100. Hagiwara S, Iwasaka H, Maeda H et al (2009) Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 31:515–520
101. Suzuki T, Morisaki H, Serita R et al (2005) Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 33:2294–2301
102. Mori K, Morisaki H, Yajima S et al (2011) Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intensive Care Med 37:1849–1856
103. Wilson J, Higgins D, Hutting H, Serkova N et al (2013) Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. Crit Care 17:R195
104. Morelli A, Donati A, Ertmer C et al (2013) Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med 41:2162–2168
105. Heilbrunn SM, Shah P, Bristow MR et al (1989) Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79:483–490
106. Berk JL, Hagen JF, Dunn JM (1970) The role of beta adrenergic blockade in the treatment of septic shock. Surg Gynecol Obstet 130:1025–1034
107. Gore DC, Wolfe RR (2006) Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery 139:686–694
108. Schmitz D, Wilsenack K, Lendemanns S et al (2007) Beta-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 72:286–294
109. Wurtman RJ (1966) Control of epinephrine synthesis by the pituitary and adrenal cortex: possible role in the pathophysiology of chronic stress. Recent Adv Biol Psychiatry 9:359–368